ABBOTT FDA Approval ANDA 084413

ANDA 084413

ABBOTT

FDA Drug Application

Application #084413

Application Sponsors

ANDA 084413ABBOTT

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL200MG0CHLORPROMAZINE HYDROCHLORIDECHLORPROMAZINE HYDROCHLORIDE

CDER Filings

ABBOTT
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 84413
            [companyName] => ABBOTT
            [docInserts] => ["",""]
            [products] => [{"drugName":"CHLORPROMAZINE HYDROCHLORIDE","activeIngredients":"CHLORPROMAZINE HYDROCHLORIDE","strength":"200MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"CHLORPROMAZINE HYDROCHLORIDE","submission":"CHLORPROMAZINE HYDROCHLORIDE","actionType":"200MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.